These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 30689517)

  • 1. Computational approach to suggest a new multi-target-directed ligand as a potential medication for Alzheimer's disease.
    Eslami M; Nezafat N; Negahdaripour M; Ghasemi Y
    J Biomol Struct Dyn; 2019 Nov; 37(18):4825-4839. PubMed ID: 30689517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined 3D-QSAR, molecular docking, and molecular dynamics study of tacrine derivatives as potential acetylcholinesterase (AChE) inhibitors of Alzheimer's disease.
    Zhou A; Hu J; Wang L; Zhong G; Pan J; Wu Z; Hui A
    J Mol Model; 2015 Oct; 21(10):277. PubMed ID: 26438408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design Synthesis and
    Remya RS; Ramalakshmi N; Nalini CN; Niraimathi V; Amuthalakshmi S
    Curr Comput Aided Drug Des; 2022; 18(4):271-292. PubMed ID: 35927818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of molecular descriptors for design of novel Isoalloxazine derivatives as potential Acetylcholinesterase inhibitors against Alzheimer's disease.
    Gurung AB; Aguan K; Mitra S; Bhattacharjee A
    J Biomol Struct Dyn; 2017 Jun; 35(8):1729-1742. PubMed ID: 27410776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, biological evaluation and molecular modeling study of novel tacrine-carbazole hybrids as potential multifunctional agents for the treatment of Alzheimer's disease.
    Thiratmatrakul S; Yenjai C; Waiwut P; Vajragupta O; Reubroycharoen P; Tohda M; Boonyarat C
    Eur J Med Chem; 2014 Mar; 75():21-30. PubMed ID: 24508831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent Acetylcholinesterase Selective and Reversible Homodimeric Agent Based on Tacrine for Theranostics.
    Meena VK; Chaturvedi S; Sharma RK; Mishra AK; Hazari PP
    Mol Pharm; 2019 Jun; 16(6):2296-2308. PubMed ID: 31059278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular perception of interactions between bis(7)tacrine and cystamine-tacrine dimer with cholinesterases as the promising proposed agents for the treatment of Alzheimer's disease.
    Eslami M; Hashemianzadeh SM; Bagherzadeh K; Seyed Sajadi SA
    J Biomol Struct Dyn; 2016; 34(4):855-69. PubMed ID: 26043757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular-docking-guided design and synthesis of new IAA-tacrine hybrids as multifunctional AChE/BChE inhibitors.
    Cheng ZQ; Zhu KK; Zhang J; Song JL; Muehlmann LA; Jiang CS; Liu CL; Zhang H
    Bioorg Chem; 2019 Mar; 83():277-288. PubMed ID: 30391700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and anti-Alzheimer's disease activity study of xanthone derivatives based on multi-target strategy.
    Kou X; Song L; Wang Y; Yu Q; Ju H; Yang A; Shen R
    Bioorg Med Chem Lett; 2020 Feb; 30(4):126927. PubMed ID: 31901382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the interactions between coumarin-derivatives and acetylcholinesterase: Examination by NMR and docking simulations.
    Tanoli NU; Tanoli SAK; Ferreira AG; Mehmood M; Gul S; Monteiro JL; Vieira LCC; Venâncio T; Correa AG; Ul-Haq Z
    J Mol Model; 2018 Jul; 24(8):207. PubMed ID: 30008113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer's disease.
    Zhu J; Yang H; Chen Y; Lin H; Li Q; Mo J; Bian Y; Pei Y; Sun H
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):496-506. PubMed ID: 29405075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A molecular approach in drug development for Alzheimer's disease.
    Agatonovic-Kustrin S; Kettle C; Morton DW
    Biomed Pharmacother; 2018 Oct; 106():553-565. PubMed ID: 29990843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinolinetrione-tacrine hybrids as multi-target-directed ligands against Alzheimer's disease.
    Uliassi E; Bergamini C; Rizzardi N; Naldi M; Cores Á; Bartolini M; Carlos Menéndez J; Bolognesi ML
    Bioorg Med Chem; 2023 Aug; 91():117419. PubMed ID: 37487339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and evaluation of novel tacrine-(β-carboline) hybrids as multifunctional agents for the treatment of Alzheimer's disease.
    Lan JS; Xie SS; Li SY; Pan LF; Wang XB; Kong LY
    Bioorg Med Chem; 2014 Nov; 22(21):6089-104. PubMed ID: 25282654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cooperative hydrogen bonds and mobility of the non-aromatic ring as selectivity determinants for human acetylcholinesterase to similar anti-Alzheimer's galantaminics: a computational study.
    Rocha REO; Lima LHF
    J Biomol Struct Dyn; 2019 Apr; 37(7):1843-1856. PubMed ID: 29697300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational Investigation of Novel Compounds as Dual Inhibitors of AChE and GSK-3β for the Treatment of Alzheimer's Disease.
    Londhe SG; Shenoy M; Kini SG; Walhekar V; Kumar D
    Curr Top Med Chem; 2024; 24(19):1738-1753. PubMed ID: 38859777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metal based donepezil analogues designed to inhibit human acetylcholinesterase for Alzheimer's disease.
    Junaid M; Islam N; Hossain MK; Ullah MO; Halim MA
    PLoS One; 2019; 14(2):e0211935. PubMed ID: 30785927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrine-resveratrol fused hybrids as multi-target-directed ligands against Alzheimer's disease.
    Jeřábek J; Uliassi E; Guidotti L; Korábečný J; Soukup O; Sepsova V; Hrabinova M; Kuča K; Bartolini M; Peña-Altamira LE; Petralla S; Monti B; Roberti M; Bolognesi ML
    Eur J Med Chem; 2017 Feb; 127():250-262. PubMed ID: 28064079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple Ligands Targeting Cholinesterases and β-Amyloid: Synthesis, Biological Evaluation of Heterodimeric Compounds with Benzylamine Pharmacophore.
    Szałaj N; Bajda M; Dudek K; Brus B; Gobec S; Malawska B
    Arch Pharm (Weinheim); 2015 Aug; 348(8):556-63. PubMed ID: 26032855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico identification of AChE and PARP-1 dual-targeted inhibitors of Alzheimer's disease.
    Hu XM; Dong W; Cui ZW; Gao CZ; Yu ZJ; Yuan Q; Min ZL
    J Mol Model; 2018 Jun; 24(7):151. PubMed ID: 29869722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.